Skip to main content

letter

. 1990 Sep;66(779):789–790. doi: 10.1136/pgmj.66.779.789

The need for new therapeutic approaches in visceral leishmaniasis during HIV infection.

A Lafeuillade, R Quilichini, C Dhiver, C Mary, J A Gastaut

PMCID: PMC2426897 PMID: 2122429

789

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Badaro R., Falcoff E., Badaro F. S., Carvalho E. M., Pedral-Sampaio D., Barral A., Carvalho J. S., Barral-Netto M., Brandely M., Silva L. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med. 1990 Jan 4;322(1):16–21. doi: 10.1056/NEJM199001043220104. [DOI] [PubMed] [Google Scholar]
Berenguer J., Moreno S., Cercenado E., Bernaldo de Quirós J. C., García de la Fuente A., Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med. 1989 Jul 15;111(2):129–132. doi: 10.7326/0003-4819-111-2-129. [DOI] [PubMed] [Google Scholar]
Condom M. J., Clotet B., Sirera G., Milla F., Foz M. Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS) Ann Intern Med. 1989 Nov 1;111(9):767–768. doi: 10.7326/0003-4819-111-9-767_2. [DOI] [PubMed] [Google Scholar]
Dellamonica P., Bernard E., Le Fichoux Y., Politano S., Carles M., Durand J., Mondain V. Allopurinol for treatment of visceral leishmaniasis in patients with AIDS. J Infect Dis. 1989 Nov;160(5):904–905. doi: 10.1093/infdis/160.5.904. [DOI] [PubMed] [Google Scholar]
Murray H. W., Berman J. D., Wright S. D. Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony. J Infect Dis. 1988 May;157(5):973–978. doi: 10.1093/infdis/157.5.973. [DOI] [PubMed] [Google Scholar]
Smith D., Gazzard B., Lindley R. P., Darwish A., Reed C., Bryceson A. D., Evans D. A. Visceral leishmaniasis (kala azar) in a patient with AIDS. AIDS. 1989 Jan;3(1):41–43. [PubMed] [Google Scholar]

ACTIONS

RESOURCES